In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
You can inject subcutaneously anywhere convenient
Changes in Appetite Deficits of vitamin B12 have also been associated with changes in appetite, including increased cravings for unhealthy foods and overeating
Journal of Alternative and Complementary Medicine
dividing your target dose by that concentration gives the volume to draw, which this tool also converts to units on a 0.3 ml, 0.5 ml, or 1 ml syringe size